Ophthalmology

Bayer Pharmaceuticals Earns UK Approval for AMD Treatment

In the UK, Bayer Pharmaceuticals, based in Leverkusen, Germany, has earned approval from the National Institute for Health and Care Excellence for its Eylea as a wet age-related macular degeneration treatment, according to a report by thepharmaletter.

Carrie Pallardy

Friday, May 31st, 2013

Eylea, aflibercept solution for injection, is only recommended if administered within the National Health Service and National Institute for Health and Care Excellence guidelines.

More Articles on Ophthalmology:
AAO Issues Statement on Pharmaceutical Compounding Legislation
BIOLASE Earns US Patent for Laser Technologies
Valeant Acquires Bausch + Lomb for $8.7B

Next Up in Ophthalmology

Illinois eye practice suffers data incident

Bloomington, Ill.-based VisionPoint Eye Center has notified certain patients that their information may have been affected in a data security…

By: Cameron Cortigiano
Tuesday, December 16th, 2025
Ophthalmologists oppose bill expanding laser procedure certifications

Ophthalmologists have raised concerns about a bill in the New Hampshire State House that would expand laser treatment certifications for…

By: Cameron Cortigiano
Wednesday, December 10th, 2025
Parker Cornea breaks ground on ophthalmology ASC

The Parker Cornea Eye Institute has broken ground on a 6,500-square-foot ASC in Birmingham, Ala. The ophthalmology-focused facility will include…

By: Cameron Cortigiano
Thursday, November 20th, 2025

Comments are closed.

Securing the future of connected care: Survey insights on cyber resilience in patient monitoring

Next Up in Ophthalmology

Illinois eye practice suffers data incident

Ophthalmologists oppose bill expanding laser procedure certifications

Parker Cornea breaks ground on ophthalmology ASC

Join the 40,000+ ASC leaders who start their day with Becker's